Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Tang, Dong ^a   Zhang, Jingqiu ^a   Yuan, Zhongxu ^b   Gao, Jun ^a   Wang, Sen ^c   Ye, Nianyuan ^a   Li, Ping ^a   Gao, Sujun ^a   Miao, Yi ^c   Wang, Daorong ^a   Jiang, Kuirong ^c  

^a NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

^b Anhui No2 Provincial People's Hospital   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1; GELATINASE A; GELATINASE B; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHRONIC PANCREATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS SATELLITE CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SATELLITE CELL; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR XENOGRAFT; UPREGULATION; AGED; ANIMAL; BIOLOGICAL MODEL; CELL SEPARATION; DISEASE COURSE; DRUG EFFECTS; ENZYMOLOGY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUDE MOUSE; PANCREAS; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; STAINING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL PROLIFERATION; CELL SEPARATION; DISEASE PROGRESSION; FEMALE; GALECTIN 1; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE, NUDE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS; STAINING AND LABELING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84897051025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090476     Document Type: Article

References (55)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. The Lancet O (2010) Pancreatic cancer: a neglected killer? Lancet Oncol 11: 1107.
3. Neesse A, Michl P, Frese KK, Feig C, Cook N, et al. (2011) Stromal biology and therapy in pancreatic cancer. Gut 60: 861-868.
4. Kuroda T, Kumagi T, Yokota T, Seike H, Nishiyama M, et al. (2013) Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinical review of 1,082 patients. BMC Gastroenterol 13: 134.
5. Luo J, Xiao L, Wu C, Zheng Y, Zhao N (2014) Correction: The Incidence and Survival Rate of Population-Based Pancreatic Cancer Patients: Shanghai Cancer Registry 2004-2009. PLoS One 9.
6. Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, et al. (2008) Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res 68: 2085-2093. (Pubitemid 351521780)
7. Xu Z, Vonlaufen A, Phillips PA, Fiala-Beer E, Zhang X, et al. (2010) Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol 177: 2585-2596.
8. Tang D, Yuan Z, Xue X, Lu Z, Zhang Y, et al. (2012) High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer. Int J Cancer 130: 2337-2348.
9. Masamune A, Satoh M, Hirabayashi J, Kasai K, Satoh K, et al. (2006) Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 290: G729-736.
10. Spano D, Russo R, Di Maso V, Rosso N, Terracciano LM, et al. (2010) Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness. Mol Med 16: 102-115.
11. Wu MH, Hong TM, Cheng HW, Pan SH, Liang YR, et al. (2009) Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol Cancer Res 7: 311-318.
12. Camby I, Le Mercier M, Lefranc F, Kiss R (2006) Galectin-1: a small protein with major functions. Glycobiology 16: 137R-157R. (Pubitemid 44530693)
13. Rabinovich GA (2005) Galectin-1 as a potential cancer target. Br J Cancer 92: 1188-1192.
14. Satelli A, Rao US (2011) Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells. Cancer Lett 301: 38-46.
15. Bektas S, Bahadir B, Ucan BH, Ozdamar SO (2010) CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance. Pathol Oncol Res 16: 569-577.
16. Wang L, Friess H, Zhu Z, Frigeri L, Zimmermann A, et al. (2000) Galectin-1 and galectin-3 in chronic pancreatitis. Lab Invest 80: 1233-1241. (Pubitemid 30637063)
17. Berberat PO, Friess H, Wang L, Zhu Z, Bley T, et al. (2001) Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. J Histochem Cytochem 49: 539-549. (Pubitemid 32295176)
18. Shen J, Person MD, Zhu J, Abbruzzese JL, Li D (2004) Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64: 9018-9026. (Pubitemid 39665512)
19. Apte MV, Park S, Phillips PA, Santucci N, Goldstein D, et al. (2004) Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 29: 179-187. (Pubitemid 39304974)
20. Bachem MG, Schunemann M, Ramadani M, Siech M, Beger H, et al. (2005) Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128: 907-921. (Pubitemid 40523543)
21. Masamune A, Kikuta K, Watanabe T, Satoh K, Hirota M, et al. (2009) Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Gut 58: 550-559.
22. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, et al. (1998) Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115: 421-432.
23. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, et al. (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918-926. (Pubitemid 351206771)
24. Ohuchida K, Mizumoto K, Murakami M, Qian LW, Sato N, et al. (2004) Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64: 3215-3222. (Pubitemid 38581425)
25. Masamune A, Kikuta K, Watanabe T, Satoh K, Satoh A, et al. (2008) Pancreatic stellate cells express Toll-like receptors. J Gastroenterol 43: 352-362. (Pubitemid 351958899)
26. Tripathi P, Tripathi AK, Kumar A, Ahmad R, Balapure AK, et al. (2009) Diagnostic and prognostic values of S-phase fraction and aneuploidy in patients with bone marrow aplasia. Indian J Hematol Blood Transfus 25: 10-16.
27. Spector I, Honig H, Kawada N, Nagler A, Genin O, et al. (2010) Inhibition of pancreatic stellate cell activation by halofuginone prevents pancreatic xenograft tumor development. Pancreas 39: 1008-1015.
28. Daroqui CM, Ilarregui JM, Rubinstein N, Salatino M, Toscano MA, et al. (2007) Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape. Cancer Immunol Immunother 56: 491-499. (Pubitemid 46204535)
29. Jiang X, Abiatari I, Kong B, Erkan M, De Oliveira T, et al. (2009) Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer. Pancreatology 9: 165-172.
30. He J, Baum LG (2006) Galectin interactions with extracellular matrix and effects on cellular function. Methods Enzymol 417: 247-256. (Pubitemid 44792713)
31. Juszczynski P, Ouyang J, Monti S, Rodig SJ, Takeyama K, et al. (2007) The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci U S A 104: 13134-13139. (Pubitemid 351737605)
32. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, et al. (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 103: 15975-15980. (Pubitemid 44657577)
33. Liu FT, Rabinovich GA (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5: 29-41.
34. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, et al. (2003) Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 63: 8614-8622. (Pubitemid 38064035)
35. Fitzner B, Walzel H, Sparmann G, Emmrich J, Liebe S, et al. (2005) Galectin-1 is an inductor of pancreatic stellate cell activation. Cell Signal 17: 1240-1247. (Pubitemid 40982614)
36. Apte MV, Pirola RC, Wilson JS (2006) Battle-scarred pancreas: role of alcohol and pancreatic stellate cells in pancreatic fibrosis. J Gastroenterol Hepatol 21 Suppl 3: S97-S101. (Pubitemid 44266561)
37. Masamune A, Satoh M, Kikuta K, Suzuki N, Satoh K, et al. (2005) Ellagic acid blocks activation of pancreatic stellate cells. Biochem Pharmacol 70: 869-878. (Pubitemid 41138851)
38. Masamune A, Watanabe T, Kikuta K, Shimosegawa T (2009) Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol 7: S48-54.
39. Ansari D, Andersson E, Andersson B, Andersson R (2010) Chronic pancreatitis: potential future interventions. Scand J Gastroenterol 45: 1022-1028.
40. Gerloff A, Singer MV, Feick P (2010) Beer and its non-alcoholic compounds: role in pancreatic exocrine secretion, alcoholic pancreatitis and pancreatic carcinoma. Int J Environ Res Public Health 7: 1093-1104.
41. Kikuta K, Masamune A, Watanabe T, Ariga H, Itoh H, et al. (2010) Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. Biochem Biophys Res Commun 403: 380-384.
42. Jung EJ, Moon HG, Cho BI, Jeong CY, Joo YT, et al. (2007) Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 120: 2331-2338.
43. Tang D, Wang D, Yuan Z, Xue X, Zhang Y, et al. (2013) Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Int J Cancer 132: 993-1003.
44. Roda O, Ortiz-Zapater E, Martinez-Bosch N, Gutierrez-Gallego R, Vila-Perello M, et al. (2009) Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.Gastroenterology 136: 1379-1390, e1371-1375.
45. Grutzmann R, Pilarsky C, Ammerpohl O, Luttges J, Bohme A, et al. (2004) Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 6: 611-622. (Pubitemid 39411099)
46. Xue X, Lu Z, Tang D, Yao J, An Y, et al. (2011) Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma. Pancreas 40: 832-839.
47. Chen R, Pan S, Ottenhof NA, de Wilde RF, Wolfgang CL, et al. (2012) Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biol Ther 13: 899-907.
48. Chung JC, Oh MJ, Choi SH, Bae CD (2008) Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma. ANZ J Surg 78: 245-251. (Pubitemid 351432692)
49. Qiu J, Gao HQ, Li BY, Shen L (2008) Proteomics investigation of protein expression changes in ouabain induced apoptosis in human umbilical vein endothelial cells. J Cell Biochem 104: 1054-1064. (Pubitemid 351830850)
50. Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, et al. (2010) Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res 70: 6216-6224.
51. Grassadonia A, Tinari N, Iurisci I, Piccolo E, Cumashi A, et al. (2004) 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj J 19: 551-556.
52. Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, et al. (2002) Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 61: 585-596. (Pubitemid 34721463)
53. Sioud M (2011) New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins. Scand J Immunol 73: 79-84.
54. Kovacs-Solyom F, Blasko A, Fajka-Boja R, Katona RL, Vegh L, et al. (2010) Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett 127: 108-118.
55. Dings RP, Van Laar ES, Loren M, Webber J, Zhang Y, et al. (2010) Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6- hydroxylpropylacylfulvene. Bioconjug Chem 21: 20-27.